ࡱ> ~} ?bjbj11 4SS6c """""6668nBD6>(( NXtB>D>D>D>D>D>D>$@]Clh>"   h>""4}>''' F""B>' B>''/: < 5i4] !;.>>0>;C!(C, <C" <$H'rUh>h>$> C : [INSERT ELECTRONIC DEPARTMENT LETTERHEAD ON PAGE 1] Consent to Procedures (Deception Study) Template v. 2/01/2016 The information highlighted in yellow is guidance. DELETE THIS AND ALL OTHER HIGHLIGHTED INSTRUCTIONS before submitting. RSRB Requirements: Use of Subject: The consent must use the term research subject rather than participant or volunteer. Use of 2nd Person: The consent form must be written in 2nd person (e.g., You are being asked to take part in a research study about). Pagination: Maintain page numbering already inserted in the footer (e.g., 2 of 4). Version Date: Manually type the date in the footer, rather than selecting Insert Date from the toolbar to avoid automatic logo each time the document is opened. Margins: Maintain the bottom margin of at least 2 inches to provide space for watermarking upon approval. Sample Language: Sample language for certain procedures and risks, (e.g., CT, MRI, X-ray, randomization, placebo, etc.) is provided in the  HYPERLINK "http://www.rochester.edu/ohsp/rsrb/docTemplates/consentFormTemplates.html" Consent Document Sample Language guide. Consent to Procedures [Insert Title of Study] Principal Investigator: [Insert] Faculty Advisor: [Insert or delete if not applicable.] This consent form describes a research study, what you may expect if you decide to take part and important information to help you make your decision. Please read this form carefully. The study staff will explain this study to you. Please ask questions about anything that is not clear before you agree to participate. You may take this consent form home to think about and discuss with family or friends. [Delete last sentence if not applicable.] Being in this study is voluntary it is your choice. If you join this study, you can change your mind and stop at any time. If you choose not to take part, your [routine medical care, employment status, educational status, etc.] will not be changed in any way. [Delete if not applicable.] There are risks from participating and you should understand what these mean to you. Introduction You are being asked to take part in this study becauseSpecify condition, situation, circumstance or other reason for recruitment to study. This study is being conducted by [insert investigator name] at the University of Rochesters Department of [insert department name]. Purpose of Study The purpose of this study is toDescribe the general purpose of the study and include relevant background information in lay terms. Reveal as much as possible without threatening your ability to test the research hypothesis. If possible, limit the explanation to why study is being done to one or two sentences. Description of Study Procedures If you decide to take part in this study, you will be asked toDescribe in plain language (i.e., use lay terms), step-by-step, what will be done or required of the research subject. Be concise; avoid describing study procedures in lengthy narrative form. If there are multiple steps, use sub-headings, bullets, tables, pictures, etc. Include where the study procedures will take place. If different procedures will take place at different locations, specify accordingly. (If applicable for documenting study participation in electronic health record) The following information about your study participation will be included in your electronic health record: Documenting you are in this study A copy of your signed consent form (If applicable for documenting study participation and research results in electronic health record) The following information about your study participation will be included in your electronic health record: Documenting you are in this study A copy of your signed consent form Results of testing from [insert protocol required assessments, e.g., MRI, CT scan, echocardiograms, etc.] OR Results of all testing done as part of this study Number of Subjects Approximately [state total accrual goal (number) here] subjects will take part in this study. If appropriate, give a short description about cohorts. Duration of the Study Your participation in the study will lastIndicate the length of time of the individual subjects active involvement. If not previously stated in the procedures section, include the expected time needed for study visits/procedures as well as the overall length of time. Risks of Participation **The risks listed in the consent form should be consistent with the protocol and application.** For each research procedure, describe immediate and long-term physical, psychological, social, legal and economic risks/discomforts. Provide sufficient description of the risks to enable subjects to decide if they want to participate. If appropriate, include information on probability of the risks and the magnitude and reversibility of harmful effects. Describe how the researchers are minimizing the risks/discomforts. (If applicable for documenting study participation in electronic health record) The study team may be notified if you receive other health care services at URMC and Affiliates (e.g., visit to the emergency room). In addition, the following individuals may know you participated in research: Staff at the University of Rochester Medical Center and its Affiliates (e.g., Strong Memorial Hospital, Highland Hospital, URMC primary care, specialist physician offices) who have a reason to access your electronic health record. Individuals who request a copy of information from your health record for activities such as treatment or payment (e.g., medical insurance companies, workers compensation). (If applicable for documenting study participation and research results in electronic health record) The study team may be notified if you receive other health care services at URMC or its Affiliates (e.g., visit to the emergency room). In addition, the following individuals may know you participated in research and may see results of testing conducted for this study: Staff at the University of Rochester Medical Center and its Affiliates (e.g., Strong Memorial Hospital, Highland Hospital, URMC primary care, specialist physician offices) who have a reason to access your electronic health record. Individuals who request a copy of information from your health record for activities such as treatment or payment (e.g., medical insurance companies, workers compensation). Benefits of Participation Choose or modify ONE of the following sentences as appropriate to the specific study: You will not benefit from being in this research study. -OR- You might not benefit from being in this research study. The potential benefit to you from being in this study might beList any direct benefits to the subject that might reasonably be expected from the research. **Payment to subjects for participation is not considered a benefit, it is an incentive. Payment information can be provided in the payment section below.** Alternatives to Participation (If applicable) Use this section to discuss appropriate procedures or courses, if any, that might be advantageous to the subject (e.g., not participating or alternative options). Sponsor Support The University of Rochester is receiving payment from [insert sponsor name] for conducting this research study. The RSRB requires that all consent forms disclose which agencies or institutions (e.g., National Institutes of Health, Department of Defense, Center for Disease Control, State agencies, foundations or industry sponsors) are funding the research. If the study is not being funded by an external agency (i.e., Department funds or personal funds) this section may be deleted. Financial Disclosure Statement (if applicable) If the Principal Investigator or any other study personnel have a conflict of interest management plan involving the study sponsor and the plan requires disclosure of the conflict in the consent form, insert disclosure statement here. Payments Choose ONE of the following options, plus additional applicable language, as appropriate to the specific study: You will not be paid for participating in this study. -OR- You will be paid $XX for taking part in this study. If subjects are to be paid for participation, specify the amount, schedule of payment and conditions for payment (e.g., You will receive $100.00 for each completed study visit. You will not be paid for visits that you do not complete. You will be paid up to a total of $1200.00.). When applicable, payments should be based on a prorated system. -OR- You will receive XX hours of departmental research credit. (If applicable) Payment received for participation in research is considered taxable income. If you receive payment for your participation in studies at the University of Rochester and its affiliates that exceeds $600.00 in any one calendar year, the University is required to report this information to the Internal Revenue Service (IRS) in a 1099 (Miscellaneous Income) form. You will be sent a copy of this form and a copy will be sent to the IRS. (If applicable) You will not receive any money that may result from any commercial tests or products that are developed as a result of this study. Reimbursement for Travel Expenses (If applicable) Include language regarding reimbursement for travel expenses, such as plane, taxi, hotel, mileage costs, and modify as applicable to the study: You will be reimbursed for reasonable out of pocket expenses after submission of receipts to the study team. You will only be reimbursed for actual expenses up to a maximum amount of $XX. Such reimbursed expenses are not taxable. Confidentiality of Records The University of Rochester makes every effort to keep the information collected from you private. In order to do so, we will [insert protection measures]. Sometimes, however, researchers need to share information that may identify you with people that work for the University, regulators or the study sponsor. If this does happen we will take precautions to protect the information you have provided. Results of the research may be presented at meetings or in publications, but your name will not be used. [If protected health information (PHI) is being collected or if you are part of the covered entity, use the standard Confidentiality of Records and HIPAA Authorization language provided in the HYPERLINK "http://www.rochester.edu/ohsp/rsrb/docTemplates/consentFormTemplates.html"RSRB Biomedical Consent Template.] Contact Persons For more information concerning this research or if you feel that your participation has resulted in any emotional or physical discomfort, please contact: [insert contact persons name] at [telephone number] Please contact the University of Rochester logo Subjects Review Board at 265 Crittenden Blvd., CU 420628, logo NY 14642, Telephone (585) 276-0005 or (877) 449-4441 [insert country code (001) if applicable] for the following reasons: You wish to talk to someone other than the research staff about your rights as a research subject; To voice concerns about the research; To provide input concerning the research process; In the event the study staff could not be reached. If there are additional informational sources related to the study (e.g., client representatives, subject advocate or individuals at other study sites as appropriate), list here with contact information. Voluntary Participation Taking part in this study is voluntary. You are free not to participate or to withdraw at any time, for whatever reason. No matter what decision you make, there will be no penalty or loss of benefits to which you are entitled. In the event that you do withdraw from this study, the information you have already provided will be kept in a confidential manner. Additional student-subject wording [delete if not applicable]: This will not affect your class standing or grades at the University of Rochester. You will not be offered or receive any special consideration if you take part in this research. Additional employee-subject wording [delete if not applicable]: Taking part in this research is not a part of your University duties, and refusing will not affect your job. You will not be offered or receive any special job-related consideration if you take part in this research. ** Insert any checkbox options for future use of biological specimens or research data, future contact, audio/video recording, etc. If possible, checkbox options & signature blocks should appear all on one page. SignatureS/Dates After reading and discussing the information in this consent form you should understand: Why this study is being done; What will happen during the study; Any possible risks and benefits to you; Other options you may have instead of being in the study; How your personal information will be protected; What to do if you have problems or questions about this study. Subject Consent I have read (or have had read to me) the contents of this consent form and have been encouraged to ask questions. I have received answers to my questions. I agree to participate in this study. I have received (or will receive) a signed copy of this form for my records and future reference. Subject Name (Printed by Subject) Signature of Subject Date Person Obtaining Consent I have read this form to the subject and/or the subject has read this form. I will provide the subject with a signed copy of this consent form. An explanation of the research was given and questions from the subject were solicited and answered to the subjects satisfaction. In my judgment, the subject has demonstrated comprehension of the information. I have given the subject adequate opportunity to read the consent before signing. Name and Title (Print) Signature of Person Obtaining Consent Date     RSRB Case Number: 000XXXX Page  PAGE 1 of  NUMPAGES 7 Version Date: xx/xx/20xx ,345\ijkmqr~dJdJ2/h3hR56B*CJOJQJ^JaJph2 *h3hh 56B*CJOJQJ^JaJph2 *h3h356B*CJOJQJ^JaJph2 *h3hR56B*CJOJQJ^JaJph2 *h3h)L56B*CJOJQJ^JaJphhQ5B*CJaJph)hARhBB*CJOJQJ^JaJph& *hBB*CJOJQJ^JaJph, *hARhBB*CJOJQJ^JaJph 45s n N ^ l m $a$gdZW$a$gdgd & Fgd& & Fgd & Fgd)Lgd)Lgd$a$gd-$a$gd)L$a$$a$gdBrsn v x ӹӹӹӞӄmRm82 *h)Lhl56B*CJOJQJ^JaJph5 *h)Lh)L56B*CJH*OJQJ^JaJph, *h)L56B*CJOJQJ^JaJph2 *h;h)L56B*CJOJQJ^JaJph5 *h3hl56;B*CJOJQJ^JaJph2 *h3hAR56B*CJOJQJ^JaJph2 *h3hl56B*CJOJQJ^JaJph#h3hh 56B*CJaJph  C D J K N i  $ , ^ p 汚汚怚fLff2 *h)Lh)L56B*CJOJQJ^JaJph2 *h)Lh^56B*CJOJQJ^JaJph2 *h)Lh&56B*CJOJQJ^JaJph, *h)L56B*CJOJQJ^JaJph2 *h)Lhl56B*CJOJQJ^JaJph5 *h)LhAR56B*CJH*OJQJ^JaJph2 *h)LhAR56B*CJOJQJ^JaJph A B C c d k l m t u ϴϖoZE0Z(hARh6Wq;B*OJQJ^JaJph(hARhl;B*OJQJ^JaJph(hARhQ;B*OJQJ^JaJphhlB*OJQJ^JaJph- *h)Lh)L0J56CJOJQJ^JaJ;j *h)L56B*CJOJQJU^JaJph5j *h)L56B*CJOJQJU^JaJph, *h)L56B*CJOJQJ^JaJph2 *h)LhAR56B*CJOJQJ^JaJph ׿ײrZC.)hZWhZWB*CJOJQJ^JaJph, *h ahZWB*CJOJQJ^JaJph/ *h ahZW5B*CJOJQJ^JaJph *hARhARCJOJQJ^J *hARhQfCJOJQJ^JhARhQf5CJOJQJ^JhARhAR5CJOJQJ^JhQf5CJOJQJ^J/ *hARhQf5B*CJOJQJ^JaJph/ *hARhAR5B*CJOJQJ^JaJph hARhQCJOJQJ^JaJ ;67DVWh] & FgdDgdD & F hh^hgd$a$gdgdBgd 9:[`)9;`aʶʨʖuudR@Rd# *h5hZCJOJQJ^JaJ# *h5h5CJOJQJ^JaJ h5hZCJOJQJ^JaJ#hZhZ>*CJOJQJ^JaJ *h5CJOJQJ^JaJ# *hZhZCJOJQJ^JaJh5CJOJQJ^JaJ&hZh1h1CJOJQJ^JaJ hZhZCJOJQJ^JaJ#hZhZ5CJOJQJ^JaJ#hQB*CJOJQJ^JaJph567CD{  Űq\H1H, *hARhMB*CJOJQJ^JaJph& *hGB*CJOJQJ^JaJph)hZhZB*CJOJQJ^JaJph# *hZhZCJOJQJ^JaJ)hARhQB*CJOJQJ^JaJph/hARhQ5>*B*CJOJQJ^JaJph)h)L5>*B*CJOJQJ^JaJph,hZhQ5B*CJOJQJ^JaJph hZhZCJOJQJ^JaJ# *h8ohZCJOJQJ^JaJ .<TUWgh5>Kì՘uccTETcu0)hGa"5>*B*CJOJQJ^JaJph *h<dCJOJQJ^JaJ *h vCJOJQJ^JaJ# *hGhGCJOJQJ^JaJ hGhGCJOJQJ^JaJ#hARhQ5CJOJQJ^JaJ&hARhQ5>*CJOJQJ^JaJ, *hGhGB*CJOJQJ^JaJph#hGB*CJOJQJ^JaJph)hARhQB*CJOJQJ^JaJph)hARhMB*CJOJQJ^JaJph2ȷ֦ȘwfT</ *hDhDB*CJOJQJ\^JaJph#hQB*CJOJQJ^JaJph hb hQCJOJQJ^JaJ *h5CJOJQJ^JaJ# *hb hb CJOJQJ^JaJh5CJOJQJ^JaJ hARh6WqCJOJQJ^JaJ hARhb CJOJQJ^JaJhb CJOJQJ^JaJ hARhQCJOJQJ^JaJ/hARhQ5>**䴳ϴ#%ѹϿ<%, *h/h|iB*CJOJQJ^JaJph)hARh|iB*CJOJQJ^JaJph#h|iB*CJOJQJ^JaJph/hARh|i5>*B*CJOJQJ^JaJph#h3B*CJOJQJ^JaJph#hBB*CJOJQJ^JaJph2 *h3h35B*CJOJQJ\^JaJph/ *h3h3B*CJOJQJ\^JaJph/ *hDhDB*CJOJQJ\^JaJph,hDhDB*CJOJQJ\^JaJphtXYZ[n+,CQRgdGa"gd1$gd$a$gd$@&gdgd|igdgdD & FgdDEF*+,CDIJzsjW@+)hGa"hB*CJOJQJ^JaJph, *hGa"hB*CJOJQJ^JaJph$ *hhB*OJQJ^JphhARhQaJ hARhxY#hxYhxY5CJOJQJ^JaJ# *h<dhxYCJOJQJ^JaJ& *h<dhxYCJOJQJ]^JaJ#hxYhxYCJOJQJ]^JaJ,hxYhxY5>*CJOJQJ\]^JaJ# *h/h|iCJOJQJ^JaJ#h|iB*CJOJQJ^JaJph  PQR  @Cr!!1!4!ɹkVC0$hARhQ5B*CJ^JaJph$hARhQ>*B*CJ^JaJph) *hDhD>*CJOJQJ\^JaJ, *hDhD5>*CJOJQJ\^JaJ#hDhDCJOJQJ\^JaJ& *hDhDCJOJQJ\^JaJ hBhGa"CJOJQJ^JaJh5B*CJ^JaJph' *hGa"h5B*CJ^JaJph *hGa"h5CJ^JaJ# *hhCJOJQJ^JaJu]  rh !!4!!!!""<#=#k#$$ $$gd $a$gd $a$gdgd1$gdgdgd & FgdDgdD4!E!H!!!!!!"7"<"?"m"r"""""""鼪yjyVD5D *h<dCJOJQJ^JaJ# *hhCJOJQJ^JaJ&hh56CJOJQJ^JaJ *h\TCJOJQJ^JaJ# *h<dhCJOJQJ^JaJh\TCJOJQJ^JaJ hhCJOJQJ^JaJ#h\TB*CJOJQJ^JaJph)hhB*CJOJQJ^JaJph/ *hh5B*CJOJQJ^JaJph, *hhB*CJOJQJ^JaJph"9#;#<#=#Z#[#j#k#$$ $V$k$l$$ʵu]L:(L#hh6CJOJQJ^JaJ# *hhCJOJQJ^JaJ hhCJOJQJ^JaJ/hh5>*B*CJOJQJ^JaJph)h 5>*B*CJOJQJ^JaJph# *hh CJOJQJ^JaJ *hh aJ h aJhARh aJ)h5>*B*CJOJQJ^JaJph&hh5>*CJOJQJ^JaJ# *hhCJOJQJ^JaJ *hfCJOJQJ^JaJ$$%%& &8&#'$'-''''k)q)))t+u+, ,;,,-gd^a q!!gdgdgdBgdgd)L$a$gdgd$$%%&& &'&7&8&"'#'$'-'IJweT@(/hARhQ5>*B*CJOJQJ^JaJph&hh5>*CJOJQJ^JaJ hhCJOJQJ^JaJ# *hhCJOJQJ^JaJ# *h)Lh)LCJOJQJ^JaJ& *hRh)L5CJOJQJ^JaJ) *h3h)L5>*CJOJQJ^JaJ#hB*CJOJQJ^JaJph#hhCJOJQJ]^JaJ& *hhCJOJQJ]^JaJ) *hh6CJOJQJ]^JaJ -'4'7''''''''((((((h)k)o)q))dzǡ~mYmE4 hhCJOJQJ^JaJ&hBhB5CJOJQJ]^JaJ& *hBh)LCJOJQJ]^JaJ *h)LCJOJQJ]^JaJhBCJOJQJ]^JaJ& *hBhBCJOJQJ]^JaJ#hBhBCJOJQJ]^JaJ& *hhCJOJQJ]^JaJ#hhCJOJQJ]^JaJ& *hBhB5CJOJQJ^JaJ# *hBhBCJOJQJ^JaJ)))))))**6+:+u+++,, ,*,+,:,;,,ȶrr``L8& *hBhB5CJOJQJ^JaJ&hBhB5>*CJOJQJ^JaJ#hBhB6CJOJQJ^JaJh)LCJOJQJ^JaJ hBhBCJOJQJ^JaJ# *hBhBCJOJQJ^JaJ$hBhx>*B*CJ^JaJph#hh6CJOJQJ^JaJ& *hh6CJOJQJ^JaJ hhCJOJQJ^JaJ# *hLhCJOJQJ^JaJ---111112G3m333444!6"6774858gd  h1$gd:m [$\$gd:m & F @ 88^8gd gd gdgd^agdB,----P.l...e///////// 0300ɹrbRERERER8R *hNm;5CJ^JaJ *h]5CJ^JaJ *hIhI5CJ^JaJhI5B*CJ^JaJphhv5B*CJ^JaJphh B}5B*CJ^JaJph' *h^ah^a5B*CJ^JaJph$h^ah^a5B*CJ^JaJphh^a5B*CJ^JaJph$hARhQ5B*CJ^JaJph$hARhQ>*B*CJ^JaJph hBhBCJOJQJ^JaJ00000 1 1 1 1111L11s[F1)hARh)(B*CJOJQJ^JaJph)hARhQB*CJOJQJ^JaJph/hARhQ5>*B*CJOJQJ^JaJph)h.EhQB*CJOJQJ^JaJph$h^ahQ5B*CJ^JaJph *h]*hI5CJ^JaJ *h]*h]5CJ^JaJ" *h]*hI0J5CJ^JaJ'j *hhD5CJU^JaJ *hhD5CJ^JaJ!j *h]*5CJU^JaJ 111111111112:2=2Z2oWE7&7& hh CJOJQJ^JaJh CJOJQJ^JaJ#hGa"B*CJOJQJ^JaJph/hARh6Wq5>*B*CJOJQJ^JaJph h.Eh.ECJOJQJ^JaJ# *h.Eh.ECJOJQJ^JaJ, *hARh B*CJOJQJ^JaJph, *hARhQB*CJOJQJ^JaJph)h.EhQB*CJOJQJ^JaJph)hARhQB*CJOJQJ^JaJph)hARh B*CJOJQJ^JaJphZ2]222222222334z4~44444ӞxgO=#h:mB*CJOJQJ^JaJph/hARhQ5>*B*CJOJQJ^JaJph h:mhQB*CJ\aJph# *h h:mB*CJ]aJph' *h h:m0J5B*CJaJph' *h:mh:m0J5B*CJaJph *h CJOJQJ^JaJ# *hh CJOJQJ^JaJh CJOJQJ^JaJ hh CJOJQJ^JaJh3CJOJQJ^JaJ4425555 6!6"6771848588ñÜxdxSE7h CJOJQJ^JaJhQCJOJQJ^JaJ h:mh:mCJOJQJ^JaJ& *h:mh:m5CJOJQJ^JaJ# *h:mh:mCJOJQJ^JaJ#hQB*CJOJQJ^JaJph)h:mh:mB*CJOJQJ^JaJph#h B}B*CJOJQJ^JaJph#h:mB*CJOJQJ^JaJph)hARhQB*CJOJQJ^JaJph)hARh:mB*CJOJQJ^JaJph5888f9g9x999:::u:::::<<%<G<H<U<t< 1$7$8$H$gdo$a$gdgd Tgd & F @ ^gd  $a$gdgd6gd 88899d9e9f9g9p9q9x9ĮjU=(=)hKTz;>*B*CJOJQJ^JaJph/h hQ;>*B*CJOJQJ^JaJph)h6;>*B*CJOJQJ^JaJph*hh65>*B*CJ]^JaJph- *hh65>*B*CJ]^JaJph- *hh65>*B*CJ]^JaJph* *hh65B*CJ]^JaJph* *hh65B*CJ]^JaJph)hD;>*B*CJOJQJ^JaJph hARh CJOJQJ^JaJ x9::::;;<$<G<H<O<Q<T<t<u<v<­ucO=O=+#hoB*CJOJQJ^JaJph#hohoCJOJQJ\^JaJ&hoho>*CJOJQJ\^JaJ#hoho5CJOJQJ^JaJ hohoCJOJQJ^JaJ#hoho>*CJOJQJ^JaJ)hohQB*CJOJQJ^JaJph)hARhQB*CJOJQJ^JaJph"hARhQ5>*OJQJ^JaJhARhQOJQJ^JaJh3OJQJ^JaJ h h CJOJQJ^JaJt<u<v<<G>H>P>g>h>u>>>>>>>>>>????gdh  1$7$8$H$gdB 1$7$8$H$gd Tgd Tgd$a$gdv<<<===F>G>H>O>g>h>o>q>t>>>>Ͷ⤒o]I7I7/jh_U#h Th TCJOJQJ\^JaJ&h Th T>*CJOJQJ\^JaJ#h Th T5CJOJQJ^JaJ h Th TCJOJQJ^JaJ#h Th T>*CJOJQJ^JaJ#hQB*CJOJQJ^JaJph#h TB*CJOJQJ^JaJph,hARhQ5B*CJOJQJ^JaJph)h ThQB*CJOJQJ^JaJph)hARhQB*CJOJQJ^JaJphhARhQaJ>>>>>>>>>>>>>>>>>>>>>>>>>>>>??????羯羯Ϣ)hARhQB*CJOJQJ^JaJphhkhh hkOJQJ^Jh3OJQJ^JmHnHu!jhhkOJQJU^J *hhkOJQJ^JhkOJQJ^JhhkOJQJ^Jjh_Uh_!2&P:p3/ =!"#$@ % DyK yK http://www.rochester.edu/ohsp/rsrb/docTemplates/consentFormTemplates.htmlyX;H,]ą'cDyK yK http://www.rochester.edu/ohsp/rsrb/docTemplates/consentFormTemplates.htmlyX;H,]ą'c^ 2 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~_HmH nH sH tH 8`8 Normal_HmH sH tH V@V  Heading 1$<@&5CJKHOJQJtH u>@>  Heading 2$@& 5>*CJ8@8  Heading 3$@&CJB@B  Heading 4$$@&a$5CJZ@Z  Heading 5$$@&a$5>*B*CJOJQJ^Jph\@\  Heading 6$$ @&a$B*CJOJQJ^JphDA D Default Paragraph FontViV  Table Normal :V 44 la (k (No List 44 Header  !4 @4 Footer  !.). Page Number2B@"2 Body TextCJH@2H  Balloon TextCJOJQJ^JaJ6U`A6 .E Hyperlink >*B*ph`^@R` :m Normal (Web)dd[$\$B*CJOJQJ^JaJphMMMNoaN :m header-a1#5CJOJQJ\^JaJo(phB'`qB 1Comment ReferenceCJaJ4@4 1 Comment Text:: 1Comment Text Char@j@@ 1Comment Subject5\FoF 1Comment Subject Char5\FV`F ]*FollowedHyperlink >*B* phPK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭V$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3N)cbJ uV4(Tn 7_?m-ٛ{UBwznʜ"Z xJZp; {/<P;,)''KQk5qpN8KGbe Sd̛\17 pa>SR! 3K4'+rzQ TTIIvt]Kc⫲K#v5+|D~O@%\w_nN[L9KqgVhn R!y+Un;*&/HrT >>\ t=.Tġ S; Z~!P9giCڧ!# B,;X=ۻ,I2UWV9$lk=Aj;{AP79|s*Y;̠[MCۿhf]o{oY=1kyVV5E8Vk+֜\80X4D)!!?*|fv u"xA@T_q64)kڬuV7 t '%;i9s9x,ڎ-45xd8?ǘd/Y|t &LILJ`& -Gt/PK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!0C)theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] 7 bbber  4!"$-'),01Z248x9v<>? "#$%'()*+-.01345789:;=>@A $-58t<?!&,/26<?Bc(( )7XX+249DFe!@ @H 0(  0(  B S  ?_GoBack _Hlt319667395 _Hlt319667396((7@@((7  " $$2l!l!%%%**>*>*5-...7      + + .;;o!o!%%%*:*R*R*9-...7  :*urn:schemas-microsoft-com:office:smarttagsStreet=*urn:schemas-microsoft-com:office:smarttags PlaceType=*urn:schemas-microsoft-com:office:smarttags PlaceName;*urn:schemas-microsoft-com:office:smarttagsaddress>*urn:schemas-microsoft-com:office:smarttags PersonName9*urn:schemas-microsoft-com:office:smarttagsplace9*urn:schemas-microsoft-com:office:smarttagsState 666666666778:% 5&m&6666666667733333333r<<Ni]^pkllmmII;;67zzh h    2 EE**Q7<??mr9<7,,-k!!%%%e' ))+0g1p1q1x1x1222222o4o46666666666666666777r<<Ni]^pkllmm67 ZQ7,,-k!!%( )Z*]*r*r*E+F+k+l+++++++++,,0g1p1q1x1x111228292r2s22222226666666666667777t ~phG IgI'q'Nv~6Erz_p$"Wl&rΒ*h^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hH ^`OJQJo(^`OJQJ^Jo(o ^`OJQJo( m ^m `OJQJo(=^=`OJQJ^Jo(o  ^ `OJQJo( ^`OJQJo(^`OJQJ^Jo(o }^}`OJQJo( @ @ ^@ `CJOJQJo(hH ^`OJQJ^Jo(hHo pp^p`OJQJo(hH @ @ ^@ `OJQJo(hH ^`OJQJ^Jo(hHo ^`OJQJo(hH ^`OJQJo(hH ^`OJQJ^Jo(hHo PP^P`OJQJo(hHh ^`OJQJo(oh^`.h pp^p`OJQJo(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJQJo(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJQJo( @ @ ^@ `CJOJQJo(hH ^`OJQJ^Jo(hHo pp^p`OJQJo(hH @ @ ^@ `OJQJo(hH ^`OJQJ^Jo(hHo ^`OJQJo(hH ^`OJQJo(hH ^`OJQJ^Jo(hHo PP^P`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hH ^`OJQJo(^`OJQJ^Jo(o ^`OJQJo( m ^m `OJQJo(=^=`OJQJ^Jo(o  ^ `OJQJo( ^`OJQJo(^`OJQJ^Jo(o }^}`OJQJo(q'_pt Igv~6El&r @ OJQJo(                  SL        SL                           b A\T&-+  h 1h` ]*hD_B0-#!Ga"%%J'35*B.f*0k89SL:C ;Nm;;?F?>B K\L)Ly9QARqmT+UZWxY]^<dQf]f|ij#j:m6Wq~qUr>wKTz1} B}5MOIZ/RFS[fo 1=RMIr{DTAD\j axh8oGVx?D'i|k#!1`^a-MG=@a-uv6Jc T3|/.E L vQ+7M)(mKi4Ol66@7@UnknownG*Ax Times New Roman5Symbol3. *Cx Arial= Arial Bold5. .[`)Tahoma;Wingdings?= *Cx Courier NewA$BCambria Math"h B' B'J''|.c'|.c!2466 3qHX?6Wq2!xx  INTRODUCTION: Mare Perevichekflagg,        Oh+'0T     (4<DLINTRODUCTION:Mare PerevichNormalekflagg3Microsoft Office Word@Ik@@ x4]@Y4]'|.՜.+,D՜.+,L hp  University of Rochesterc6 INTRODUCTION: Title 8@ _PID_HLINKSA [CJhttp://www.rochester.edu/ohsp/rsrb/docTemplates/consentFormTemplates.html[CJhttp://www.rochester.edu/ohsp/rsrb/docTemplates/consentFormTemplates.html  !"#$%&'()*+,-./0123456789:;<=>?@ABDEFGHIJLMNOPQRSTUVWXYZ[\]^_`abcdefghijklnopqrstvwxyz{|Root Entry Fi4]Data C1TableKCWordDocument4SummaryInformation(mDocumentSummaryInformation8uCompObjr  F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q